Skip to content

The Dorsogluteal Site: Why This is What is No Longer a Recommended IM Injection Site?

2 min read

Did you know that cases of serious nerve damage and poor medication absorption have led to the abandonment of certain intramuscular (IM) injection practices? Due to these significant risks, the dorsogluteal site is what is no longer a recommended IM injection site in modern clinical practice, a change driven by a commitment to enhanced patient safety.

Quick Summary

The dorsogluteal area is no longer recommended for intramuscular injections because of its proximity to the sciatic nerve and risk of poor drug absorption. Safer sites like the ventrogluteal and deltoid are now standard.

Key Points

  • Outdated Practice: The dorsogluteal site is what is no longer a recommended IM injection site due to significant safety risks.

  • Major Risk: Sciatic Nerve Injury: The close proximity of the sciatic nerve to the dorsogluteal area can lead to permanent nerve damage, paralysis, and severe pain.

  • Poor Absorption: Injections into the dorsogluteal area frequently result in medication being poorly absorbed or delivered into the subcutaneous tissue, reducing effectiveness.

  • Safer Alternatives: The ventrogluteal, deltoid, and vastus lateralis sites are now the standard, recommended locations for IM injections.

  • Ventrogluteal is Preferred: The ventrogluteal site is the safest option for larger volumes because it is free of major nerves and vessels and offers a large, thick muscle mass.

  • Rectus Femoris Risks: The rectus femoris site is also generally no longer recommended due to increased pain and vascular risk.

  • Best Practices: Proper site selection, landmarking, and technique like the Z-track method (where applicable) are crucial for safe IM injection administration.

In This Article

The Shift Away from the Dorsogluteal Site

For decades, the dorsogluteal site, located in the upper outer quadrant of the buttock, was a common location for administering intramuscular injections. It was used for larger volume injections and seemed straightforward. However, advances in medical understanding revealed significant dangers, leading to a shift in standard protocols. Today, healthcare professionals avoid this site in favor of safer alternatives.

The Dangers of the Dorsogluteal Site

The primary concern with the dorsogluteal site is the potential for severe nerve damage and other complications due to its complex anatomy.

Proximity to the Sciatic Nerve The sciatic nerve runs near the traditional dorsogluteal injection area. An incorrectly placed injection can injure this nerve, causing pain, numbness, tingling, and potentially permanent paralysis. Anatomical variations further increase this risk.

Poor Medication Absorption Studies indicate that the dorsogluteal site can result in poor medication absorption. Research shows that many injections intended for muscle were delivered into subcutaneous tissue, hindering the drug's effectiveness. Patient obesity can also make it difficult to reach the muscle.

Vascular and Other Complications The area is close to major blood vessels like the superior gluteal artery. Accidental vascular puncture can cause hematomas or dangerous intravascular injection. Other risks include abscesses, muscle fibrosis, and gangrene.

Safer, Modern Alternatives for IM Injections

Modern practice favors safer alternatives, with the ventrogluteal site often being preferred.

The Ventrogluteal Site Located on the side of the hip, the ventrogluteal site is considered safe and effective for IM injections, especially for larger volumes. It offers clear bony landmarks, is free from major nerves and blood vessels, and has thick muscle mass for proper absorption.

The Deltoid Muscle The deltoid in the upper arm is common for smaller volumes (under 2 mL) and vaccinations.

The Vastus Lateralis Muscle On the anterolateral thigh, this large muscle is often used for infants and young children, as well as adults, for volumes up to 3 mL.

Comparing IM Injection Sites

A comparison of the outdated dorsogluteal site and the preferred ventrogluteal alternative can be found on {Link: Elsevier Health elsevier.health}.

The Role of Best Practices

Safe IM injection also involves best practices. These include the Z-track Method for irritating medications, often not aspirating for vaccinations in recommended sites, and generally avoiding massaging.

The Case of the Rectus Femoris

The rectus femoris muscle in the thigh is generally no longer recommended as an IM injection site.

Conclusion

Modern patient care emphasizes evidence-based practices like avoiding the dorsogluteal site for IM injections. Shifting to safer alternatives such as the ventrogluteal site minimizes risks and improves medication delivery. For more information on safe injection techniques, a comprehensive guide can be found at the {Link: NCBI Bookshelf https://www.ncbi.nlm.nih.gov/books/NBK556121/}.

Frequently Asked Questions

The dorsogluteal site is no longer used due to its high risk of injuring the sciatic nerve and major blood vessels, which can lead to severe pain and permanent paralysis. There is also a risk of poor medication absorption.

The main recommended alternative sites are the ventrogluteal muscle (on the hip), the vastus lateralis muscle (on the thigh), and the deltoid muscle (on the upper arm).

The ventrogluteal site is widely considered the safest IM injection site because it is free of major nerves and blood vessels and features a large, thick muscle mass for reliable absorption.

No, the rectus femoris is generally no longer considered a safe injection site due to the potential for causing more pain and damage to nearby blood vessels and nerves compared to other options.

Proper landmarking is crucial to ensure the injection is delivered into the muscle tissue while avoiding critical underlying structures like nerves and blood vessels. Incorrect landmarking can lead to ineffective medication delivery and serious injury.

For most modern IM injection sites, especially for vaccinations, the practice of aspiration (pulling back the plunger) is no longer recommended, as the risk of striking a large vessel is minimal. For some medications, professional discretion or agency policy may still require it.

In children, especially those under three, the dorsogluteal muscle is not well-developed. The sciatic nerve occupies a larger portion of the area, making it an especially high-risk site for potential nerve injury.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.